Vaccination News Home Page                 Scandals                           subscribe NewsLetter

http://adc.bmjjournals.com/cgi/content/abstract/fetalneonatal%3b88/3/F179

Full Text of this Article Reprint (PDF) Version of this Article Email this link to a friend eLetters: Submit a response to this article Similar articles found in: ADC Online PubMed PubMed Citation Search Medline for articles by: Stevens, J P || Harvey, D Alert me when: new articles cite this article   Download to Citation Manager

Collections under which this article appears: Other Infectious Diseases Other Neurology Guidelines Perinatal

Archives of Disease in Childhood Fetal and Neonatal Edition 2003;88:F179
© 2003 Archives of Disease in Childhood Fetal and Neonatal Edition
 

Long term outcome of neonatal meningitis

J P Stevens¹, M Eames², A Kent³, S Halket⁴, D Holt⁴ and D Harvey⁵

¹ University of Alberta, 3A3.43 Stollery Children’s Hospital, Edmonton, Alberta T6G 2B7, Canada
² Public Health Intelligence, Bedfordshire and Hertfordshire Health Authority, Tonman House, St Albans, Herts AL1 3ER, UK
³ Department of Clinical Psychology, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK
⁴ Karim Centre for Meningitis Research, ICSM, Department of Paediatrics and Neonatal Medicine, Queen Charlotte’s and Chelsea Hospital, Ducane Road, London W12 0NN, UK
⁵ Department of Paediatrics and Neonatal Medicine, Hammersmith Hospital, Du Cane Rd, London W12 0NN, UK

Correspondence to:
Dr Stevens, University of Alberta, 3A3.43 Stollery Children’s Hospital, Edmonton, Alberta T6G 2B7, Canada;
js20@ualberta.ca

Objectives: To quantify long term impairment after neonatal meningitis.

Design: Longitudinal case-control study over 9–10 years.

Subjects and methods: A total of 111 children who had suffered neonatal meningitis were seen and compared with 113 matched controls from their birth hospital and 49 controls from general practices. Assessments included the WISC III^UK , movement assessment battery for children (mABC), audiometry, vision testing, and social and medical data. Statistical analysis was by multiple regression, analysis of variance, and ² tests.

Results: Some 10.8% of cases had a severe and 9% a moderate overall outcome compared with 0% and 1.8% for the hospital controls. The mean intelligence quotient (IQ) of the cases (88.8) was significantly less than that of the hospital controls (99.4) or the GP controls (99.6) . The mABC score was significantly worse for the cases (7.08) than the hospital (5) or GP (4) controls. Some 3.6% of cases had sensorineural hearing loss, 2.7% had persisting hydrocephalus; no controls did. Some 5.4% of cases and 1.7% of hospital controls had treatment for seizures.

Conclusions: Severe neurodisability and milder motor and psychometric impairment result from neonatal meningitis. Both clinical follow up and comprehensive developmental assessment are needed after this disease.

Keywords: meningitis; outcome; neurodevelopment

Abbreviations: GBS, group B streptococci; GP, general practitioner; WISC-III^UK, Wechsler intelligence scale for children; mABC, movement assessment battery for children; IQ, intelligence quotient

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.